🔹 𝗖𝗣𝗛𝗜 𝗙𝗿𝗮𝗻𝗸𝗳𝘂𝗿𝘁 | 𝗢𝗰𝘁 𝟮𝟴–𝟯𝟬 | 𝗕𝗼𝗼𝘁𝗵 #𝟰.𝟭 𝗖𝟲𝟮 In a world where 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆, 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀, 𝗮𝗻𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗺𝗼𝗱𝗮𝗹𝗶𝘁𝗶𝗲𝘀 evolve by the month, how do biotech teams stay ahead? We’re here to help. Meet our leadership in Frankfurt: • 𝗔𝗹𝗲𝘅 𝗖𝗵𝗲𝗻, 𝗣𝗵𝗗 — 𝗚𝗿𝗼𝘂𝗽 𝗖𝗘𝗢 • Yongqiang Li, PhD — 𝗖𝗘𝗢, 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗖𝗗𝗠𝗢 From 𝘀𝗺𝗮𝗹𝗹 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀 to 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 and 𝗻𝘂𝗰𝗹𝗲𝗶𝗰 𝗮𝗰𝗶𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, Crystal Pharmatech supports phase-appropriate 𝗖𝗠𝗖 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆, integrated 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹/𝗯𝗶𝗼𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀, and scalable development pathways that keep programs moving toward First-in-Human and beyond—with speed, quality, and clarity. Heading to Messe Frankfurt? Let’s compare notes on your next milestone and map a smarter route to clinic. 📩 𝗕𝗼𝗼𝗸 𝗮 𝗺𝗲𝗲𝘁𝗶𝗻𝗴: Contact@crystalpharmatech.com #CPHI #CPHIFrankfurt #Biotech #CMC #SmallMolecule #Biologics #NucleicAcids #DrugDevelopment #FirstInHuman #CDMO #CRO #CrystalPharmatech
Crystal Pharmatech’s Post
More from this author
-
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
-
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
-
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development